Actively Recruiting
Optimal Implementation of Antimicrobial Stewardship in General Practice
Led by University of Wollongong · Updated on 2026-05-12
120
Participants Needed
4
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This trial aims to increase the use of antimicrobial stewardship resources when treating patients with respiratory tract infections. This trial is set in Australian general practices (family medicine or primary care). The main question it aims to answer is which type of implementation activities increase the use of antimicrobial stewardship resources. Researchers will compare doctors who receive face-to-face implementation activities (the Integrated Network group) to those who received virtual or online activities (the Virtual Network group). The primary hypothesis is that there will be a difference in how often interventions are used Participating doctors will be asked to record how often they use antimicrobial stewardship resources and which interventions they prefer. Participating practices will also provide researchers data on how many patients the doctors see. Patients with respiratory tract infections who saw a participating doctor will be asked to give feedback on their experience using surveys. A subgroup of doctors, practice staff, and patients will interviewed about their experience in the study.
CONDITIONS
Official Title
Optimal Implementation of Antimicrobial Stewardship in General Practice
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Practice is located in New South Wales, Queensland, Tasmania, or Victoria
- At least two general practitioners per practice consent to participate
- At least one practice staff member consents to participate
- A staff member from the practice will provide 90 minutes of administrative support every two weeks
- Doctors work at a participating practice at least three days per week
- Patients consulted with a participating general practitioner for a respiratory tract infection
- Patients who re-consulted or were hospitalized for a respiratory tract infection
- Patients completed a patient survey
- Patients participating in interviews have consulted with a participating doctor, completed a survey, and can read and speak English
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 4 locations
1
University of Wollogongong
Wollongong, New South Wales, Australia, 2500
Actively Recruiting
2
Bond University
Gold Coast, Queensland, Australia, 4226
Actively Recruiting
3
University of Tasmania
Hobart, Tasmania, Australia, 7005
Actively Recruiting
4
Monash University
Melbourne, Victoria, Australia, 3800
Actively Recruiting
Research Team
C
Colin H Cortie, PhD
CONTACT
A
Andrew Bonney, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here